CoChat
Cited by 29

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

MicroRNAs in diabetic cardiomyopathy and clinical perspectives

Zhou, Qiulian, Lv, Dongchao, Chen, Ping, Xu, Tianzhao, Fu, Siyi, Li, Jin, Bei, Yihua · 2014 · Frontiers in Genetics

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fgene.2014.00185

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 32

  1. Aksnes, 2007, Impact of new-onset diabetes mellitus on cardiac outcomes in the Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial population, Hypertension, 50, 467, 10.1161/HYPERTENSIONAHA.106.085654 · DOI
  2. Asrih, 2013, Emerging role of epigenetics and miRNA in diabetic cardiomyopathy, Cardiovasc. Pathol, 22, 117, 10.1016/j.carpath.2012.07.004 · DOI
  3. Bartel, 2004, MicroRNAs: genomics, biogenesis, mechanism, and function, Cell, 116, 281, 10.1016/S0092-8674(04)00045-5 · DOI
  4. Baseler, 2012, miR-141 as a regulator of the mitochondrial phosphate carrier (Slc25a3) in the type 1 diabetic heart, Am. J. Physiol. Cell Physiol, 303, C1244, 10.1152/ajpcell.00137.2012 · DOI
  5. Chavali, 2013, Predictors and prevention of diabetic cardiomyopathy, Diabetes Metab. Syndr. Obes, 6, 151, 10.2147/DMSO.S30968 · DOI
  6. Chavali, 2014, Differential expression of dicer, miRNAs, and inflammatory markers in diabetic Ins2+/- Akita hearts, Cell Biochem. Biophys, 68, 25, 10.1007/s12013-013-9679-4 · DOI
  7. Chen, 2010, Transcriptional coactivator p300 regulates glucose-induced gene expression in endothelial cells, Am. J. Physiol. Endocrinol. Metab, 298, E127, 10.1152/ajpendo.00432.2009 · DOI · Paper page
  8. Fabbri, 2010, miRNAs as molecular biomarkers of cancer, Expert Rev. Mol. Diagn, 10, 435, 10.1586/erm.10.27 · DOI
  9. Feng, 2008, Regulation of cardiomyocyte hypertrophy in diabetes at the transcriptional level, Am. J. Physiol. Endocrinol. Metab, 294, E1119, 10.1152/ajpendo.00029.2008 · DOI
  10. Feng, 2010, miR133a regulates cardiomyocyte hypertrophy in diabetes, Diabetes Metab. Res. Rev, 26, 40, 10.1002/dmrr.1054 · DOI · Paper page
  11. Fu, 2013, MicroRNA basis of physiological hypertrophy, Front. Genet, 4, 10.3389/fgene.2013.00253 · DOI
  12. Huynh, 2014, Diabetic cardiomyopathy: mechanisms and new treatment strategies targeting antioxidant signaling pathways, Pharmacol. Ther, 142, 375, 10.1016/j.pharmthera.2014.01.003 · DOI · Paper page
  13. Karolina, 2011, MicroRNA 144 impairs insulin signaling by inhibiting the expression of insulin receptor substrate 1 in type 2 diabetes mellitus, PLoS ONE, 6, e22839, 10.1371/journal.pone.0022839 · DOI · Paper page
  14. Katare, 2011, Intravenous gene therapy with PIM-1 via a cardiotropic viral vector halts the progression of diabetic cardiomyopathy through promotion of prosurvival signaling, Circ. Res, 108, 1238, 10.1161/CIRCRESAHA.110.239111 · DOI
  15. Kong, 2011, Significance of serum microRNAs in pre-diabetes and newly diagnosed type 2 diabetes: a clinical study, Acta Diabetol, 48, 61, 10.1007/s00592-010-0226-0 · DOI · Paper page
  16. Lim, 2005, Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs, Nature, 433, 769, 10.1038/nature03315 · DOI · Paper page
  17. Lu, 2010, MicroRNA-223 regulates Glut4 expression and cardiomyocyte glucose metabolism, Cardiovasc. Res, 86, 410, 10.1093/cvr/cvq010 · DOI · Paper page
  18. McClelland, 2014, microRNA in the development of diabetic complications, Clin. Sci. Lond. Engl, 126, 95, 10.1042/CS20130079 · DOI
  19. Ruiz, 2013, MicroRNAs: the underlying mediators of pathogenetic processes in vascular complications of diabetes, Can. J. Diabetes, 37, 339, 10.1016/j.jcjd.2013.07.003 · DOI
  20. Shan, 2010, miR-1/miR-206 regulate Hsp60 expression contributing to glucose-mediated apoptosis in cardiomyocytes, FEBS Lett, 584, 3592, 10.1016/j.febslet.2010.07.027 · DOI · Paper page
  21. Shantikumar, 2012, Role of microRNAs in diabetes and its cardiovascular complications, Cardiovasc. Res, 93, 583, 10.1093/cvr/cvr300 · DOI · Paper page
  22. Shen, 2011, MicroRNAs involved in the mitogen-activated protein kinase cascades pathway during glucose-induced cardiomyocyte hypertrophy, Am. J. Pathol, 179, 639, 10.1016/j.ajpath.2011.04.034 · DOI
  23. Styskal, 2012, Oxidative stress and diabetes: what can we learn about insulin resistance from antioxidant mutant mouse models?, Free Radic. Biol. Med, 52, 46, 10.1016/j.freeradbiomed.2011.10.441 · DOI · Paper page
  24. Tijsen, 2012, Circulating microRNAs as diagnostic biomarkers for cardiovascular diseases, Am. J. Physiol. Heart Circ. Physiol, 303, H1085, 10.1152/ajpheart.00191.2012 · DOI · Paper page
  25. Tyagi, 2011, Synergy of microRNA and stem cell: a novel therapeutic approach for diabetes mellitus and cardiovascular diseases, Curr. Diabetes Rev, 7, 367, 10.2174/157339911797579179 · DOI
  26. Van Rooij, 2011, The art of microRNA research, Circ. Res, 108, 219, 10.1161/CIRCRESAHA.110.227496 · DOI · Paper page
  27. Vickers, 2014, MicroRNAs in the onset and development of cardiovascular disease, Clin. Sci. Lond. Engl, 126, 183, 10.1042/CS20130203 · DOI
  28. Xiao, 2012, MicroRNA-204 is required for differentiation of human-derived cardiomyocyte progenitor cells, J. Mol. Cell. Cardiol, 53, 751, 10.1016/j.yjmcc.2012.08.024 · DOI
  29. Xu, 2012, Circulating microRNAs: novel biomarkers for cardiovascular diseases, J. Mol. Med. Berl. Ger, 90, 865, 10.1007/s00109-011-0840-5 · DOI · Paper page
  30. Yildirim, 2013, Relationship between downregulation of miRNAs and increase of oxidative stress in the development of diabetic cardiac dysfunction: junctin as a target protein of miR-1, Cell Biochem. Biophys, 67, 1397, 10.1007/s12013-013-9672-y · DOI
  31. Yu, 2008, Glucose induces apoptosis of cardiomyocytes via microRNA-1 and IGF-1, Biochem. Biophys. Res. Commun, 376, 548, 10.1016/j.bbrc.2008.09.025 · DOI · Paper page
  32. Zampetaki, 2010, Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes, Circ. Res, 107, 810, 10.1161/CIRCRESAHA.110.226357 · DOI · Paper page

Cited by

Metadata

Authors
Zhou, Q., Lv, D., Chen, P., Xu, T., Fu, S., Li, J., & Bei, Y.
Venue
Frontiers in Genetics
Published
2014-06-25
Volume
5
ISSN
1664-8021
Cited by
29
References
2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.